Cargando…
PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling
PKC-δ is an important molecule for B-cell proliferation and tolerance. B cells have long been recognized to play a part in osteoimmunology and pathological bone loss. However, the role of B cells with PKC-δ deficiency in bone homeostasis and the underlying mechanisms are unknown. We generated mice w...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494897/ https://www.ncbi.nlm.nih.gov/pubmed/32938907 http://dx.doi.org/10.1038/s41419-020-02947-3 |
_version_ | 1783582823407419392 |
---|---|
author | Li, Shangfu Liu, Qiuli Wu, Depeng He, Tianwei Yuan, Jinbo Qiu, Heng Tickner, Jennifer Zheng, Song Guo Li, Xiaojuan Xu, Jiake Rong, Limin |
author_facet | Li, Shangfu Liu, Qiuli Wu, Depeng He, Tianwei Yuan, Jinbo Qiu, Heng Tickner, Jennifer Zheng, Song Guo Li, Xiaojuan Xu, Jiake Rong, Limin |
author_sort | Li, Shangfu |
collection | PubMed |
description | PKC-δ is an important molecule for B-cell proliferation and tolerance. B cells have long been recognized to play a part in osteoimmunology and pathological bone loss. However, the role of B cells with PKC-δ deficiency in bone homeostasis and the underlying mechanisms are unknown. We generated mice with PKC-δ deletion selectively in B cells by crossing PKC-δ-loxP mice with CD19-Cre mice. We studied their bone phenotype using micro-CT and histology. Next, immune organs were obtained and analyzed. Western blotting was used to determine the RANKL/OPG ratio in vitro in B-cell cultures, ELISA assay and immunohistochemistry were used to analyze in vivo RANKL/OPG balance in serum and bone sections respectively. Finally, we utilized osteoclastogenesis to study osteoclast function via hydroxyapatite resorption assay, and isolated primary calvaria osteoblasts to investigate osteoblast proliferation and differentiation. We also investigated osteoclast and osteoblast biology in co-culture with B-cell supernatants. We found that mice with PKC-δ deficiency in B cells displayed an osteopenia phenotype in the trabecular and cortical compartment of long bones. In addition, PKC-δ deletion resulted in changes of trabecular bone structure in association with activation of osteoclast bone resorption and decrease in osteoblast parameters. As expected, inactivation of PKC-δ in B cells resulted in changes in spleen B-cell number, function, and distribution. Consistently, the RANKL/OPG ratio was elevated remarkably in B-cell culture, in the serum and in bone specimens after loss of PKC-δ in B cells. Finally, in vitro analysis revealed that PKC-δ ablation suppressed osteoclast differentiation and function but co-culture with B-cell supernatant reversed the suppression effect, as well as impaired osteoblast proliferation and function, indicative of osteoclast–osteoblast uncoupling. In conclusion, PKC-δ plays an important role in the interplay between B cells in the immune system and bone cells in the pathogenesis of bone lytic diseases. |
format | Online Article Text |
id | pubmed-7494897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74948972020-10-01 PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling Li, Shangfu Liu, Qiuli Wu, Depeng He, Tianwei Yuan, Jinbo Qiu, Heng Tickner, Jennifer Zheng, Song Guo Li, Xiaojuan Xu, Jiake Rong, Limin Cell Death Dis Article PKC-δ is an important molecule for B-cell proliferation and tolerance. B cells have long been recognized to play a part in osteoimmunology and pathological bone loss. However, the role of B cells with PKC-δ deficiency in bone homeostasis and the underlying mechanisms are unknown. We generated mice with PKC-δ deletion selectively in B cells by crossing PKC-δ-loxP mice with CD19-Cre mice. We studied their bone phenotype using micro-CT and histology. Next, immune organs were obtained and analyzed. Western blotting was used to determine the RANKL/OPG ratio in vitro in B-cell cultures, ELISA assay and immunohistochemistry were used to analyze in vivo RANKL/OPG balance in serum and bone sections respectively. Finally, we utilized osteoclastogenesis to study osteoclast function via hydroxyapatite resorption assay, and isolated primary calvaria osteoblasts to investigate osteoblast proliferation and differentiation. We also investigated osteoclast and osteoblast biology in co-culture with B-cell supernatants. We found that mice with PKC-δ deficiency in B cells displayed an osteopenia phenotype in the trabecular and cortical compartment of long bones. In addition, PKC-δ deletion resulted in changes of trabecular bone structure in association with activation of osteoclast bone resorption and decrease in osteoblast parameters. As expected, inactivation of PKC-δ in B cells resulted in changes in spleen B-cell number, function, and distribution. Consistently, the RANKL/OPG ratio was elevated remarkably in B-cell culture, in the serum and in bone specimens after loss of PKC-δ in B cells. Finally, in vitro analysis revealed that PKC-δ ablation suppressed osteoclast differentiation and function but co-culture with B-cell supernatant reversed the suppression effect, as well as impaired osteoblast proliferation and function, indicative of osteoclast–osteoblast uncoupling. In conclusion, PKC-δ plays an important role in the interplay between B cells in the immune system and bone cells in the pathogenesis of bone lytic diseases. Nature Publishing Group UK 2020-09-16 /pmc/articles/PMC7494897/ /pubmed/32938907 http://dx.doi.org/10.1038/s41419-020-02947-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Li, Shangfu Liu, Qiuli Wu, Depeng He, Tianwei Yuan, Jinbo Qiu, Heng Tickner, Jennifer Zheng, Song Guo Li, Xiaojuan Xu, Jiake Rong, Limin PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling |
title | PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling |
title_full | PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling |
title_fullStr | PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling |
title_full_unstemmed | PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling |
title_short | PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling |
title_sort | pkc-δ deficiency in b cells displays osteopenia accompanied with upregulation of rankl expression and osteoclast–osteoblast uncoupling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494897/ https://www.ncbi.nlm.nih.gov/pubmed/32938907 http://dx.doi.org/10.1038/s41419-020-02947-3 |
work_keys_str_mv | AT lishangfu pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT liuqiuli pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT wudepeng pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT hetianwei pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT yuanjinbo pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT qiuheng pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT ticknerjennifer pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT zhengsongguo pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT lixiaojuan pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT xujiake pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling AT ronglimin pkcddeficiencyinbcellsdisplaysosteopeniaaccompaniedwithupregulationofranklexpressionandosteoclastosteoblastuncoupling |